| USD millions | FY2021 | FY2022 | FY2023 | FY2024 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.3 | 5.7 | 5.0 | — | — | — | — | — | |
| Cost of revenue | — | 0.1 | — | — | — | — | — | — | |
| Gross profit | 0.6 | 0.7 | — | — | — | — | — | — | |
| Research & development | — | 11.7 | 4.5 | 5.2 | 1.2 | 0.2 | 0.1 | −22.1% | |
| Operating expenses | — | 28.3 | 14.8 | 11.3 | 5.8 | 13.2 | 16.1 | +21.8% | |
| Operating income | — | (22.7) | (14.8) | (11.3) | (5.8) | (13.2) | (16.1) | −21.8% | |
| Interest expense | — | — | — | 1.5 | 0.9 | 1.0 | — | — | |
| Interest income | — | — | — | — | 0.1 | 0.7 | 0.9 | +23.5% | |
| Pre-tax income | (20.4) | (17.9) | (13.9) | (12.5) | (6.2) | (17.0) | (22.9) | −35.0% | |
| Income tax | — | 0.0 | 0.0 | (0.0) | 0.0 | 0.0 | (0.0) | — | |
| Net income | (20.4) | (17.9) | (18.6) | (13.4) | (6.3) | (17.0) | (22.9) | −35.0% | |
| EPS, basic (per share) | — | (6.10) | (4.85) | (132.25) | (17.55) | (8.11) | — | — | |
| EPS, diluted (per share) | — | — | — | (132.25) | (17.55) | (8.11) | — | — | |
| EBITDA | — | (22.5) | (14.7) | (11.3) | — | — | — | — | |
| Depreciation & amortization | — | 0.1 | 0.0 | 0.0 | — | — | — | — | |
| Weighted average shares (shares) | — | 2,933,487 | 3,840,340 | 101,454 | 361,587 | 2,407,817 | — | — | |
| Weighted average diluted shares (shares) | — | — | 3,840,340 | 101,454 | 361,587 | 2,407,817 | — | — | |
| Gross margin | 14.6% | 12.2% | — | — | — | — | — | — | |
| Operating margin | — | −400.9% | −296.2% | — | — | — | — | — | |
| Net margin | −474.2% | −316.6% | −374.0% | — | — | — | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
